Analyzing bioimpedance in healthy newborns in China
Application of Bioimpedance Vector Analysis in Neonates
This study looks at how body composition in healthy newborns in China is measured using a special tool to see if it differs from babies in other countries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | N/A to 24 Hours |
| Sex | All |
| Sponsor | Zhujiang Hospital Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06188377 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the distribution of bioimpedance vectors in healthy neonates within the first 24 hours of life in China. Using a NUTRILAB impedance analyzer, the study will collect demographic and health data from medical records and perform bioimpedance analysis on randomly selected newborns. Measurements will be taken under controlled conditions to ensure accuracy, and the results will be compared to similar data from other countries to assess any differences in bioimpedance distribution.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy term neonates of both sexes within 24 hours of birth.
Not a fit: Patients who may not benefit from this study include those with diseases or conditions affecting body composition, such as heart failure or congenital anomalies.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the normal bioimpedance characteristics of neonates, aiding in better health assessments.
How similar studies have performed: While this approach is observational and may have been used in other contexts, the specific application of bioimpedance vector analysis in healthy neonates is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Healthy term neonates of both sexes within 24 hours. 2. Neonates whose parents or guardians consent with the research. Exclusion Criteria: 1. Infants with some disease and conditions that could interfere in the body composition (such as heart failure, blue light irradiation, sepsis, kidney injury, hepatic failure, transfusion) and newborns with congenital anomalies and/or genetic problems. 2. Neonates whose parents or guardians refuse to participate in the research.
Where this trial is running
Guangzhou, Guangdong
- Zhujiang Hospital of Southern Medical University — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Tian Zhichen, master
- Email: tianzhichen63@163.com
- Phone: +8613066385364
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.